Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 61101 - 61125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Puerarin	Investigational	NOS3	4846	upregulated	puerarin results in increased expression of NOS3 mRNA	7q36.1	A21627
Puerarin	Investigational	PGR	5241	downregulated	puerarin results in decreased expression of PGR mRNA	11q22.1	A21627
Puerarin	Investigational	PLOD3	8985	upregulated	puerarin results in increased expression of PLOD3 mRNA	7q22.1	A21627
Puerarin	Investigational	PML	5371	downregulated	puerarin results in decreased expression of PML mRNA alternative form	15q24.1	A23724
Puerarin	Investigational	PPARG	5468	downregulated	puerarin results in decreased expression of PPARG mRNA	3p25.2	A21627
Puerarin	Investigational	PTGER1	5731	downregulated	puerarin results in decreased expression of PTGER1 mRNA	19p13.1	A21627
Puerarin	Investigational	RARA	5914	downregulated	puerarin results in decreased expression of RARA mRNA alternative form	17q21.2	A23724
Puerarin	Investigational	RARA	5914	upregulated	puerarin results in increased expression of RARA mRNA	17q21.2	A21627
Puerarin	Investigational	SOD3	6649	downregulated	puerarin results in decreased expression of SOD3 mRNA	4p15.2	A21627
Puerarin	Investigational	SRD5A2	6716	downregulated	puerarin results in decreased expression of SRD5A2 mRNA	2p23.1	A21627
Puerarin	Investigational	TERT	7015	downregulated	puerarin results in decreased expression of TERT mRNA	5p15.33	A21627
Puerarin	Investigational	TPT1	7178	upregulated	puerarin results in increased expression of TPT1 mRNA	13q14.13	A21627
Puerarin	Investigational	TXN	7295	upregulated	puerarin results in increased expression of TXN mRNA	9q31.3	A21627
Puerarin	Investigational	TYRP1	7306	downregulated	puerarin results in decreased expression of TYRP1 mRNA	9p23	A21627
Puromycin	Experimental	ABCC1	4363	upregulated	Puromycin results in increased expression of ABCC1 mRNA	16p13.11	A20677
Puromycin	Experimental	CYP1A1	1543	upregulated	Puromycin results in increased expression of CYP1A1 mRNA	15q24.1	A20674
Puromycin	Experimental	LDLR	3949	downregulated	Puromycin results in decreased expression of LDLR mRNA	19p13.2	A23725
Pyrazole	Investigational	CYP2A6	1548	upregulated	pyrazole results in increased expression of CYP2A6 mRNA	19q13.2	A23617
Pyrethrum extract	Approved	CYP2B6	1555	upregulated	Pyrethrins results in increased expression of CYP2B6 mRNA	19q13.2	A23726
Pyrethrum extract	Approved	CYP3A4	1576	upregulated	Pyrethrins results in increased expression of CYP3A4 mRNA	7q22.1	A23726
Pyridoxine	Approved Investigational Nutraceutical Vet Approved	PPARGC1A	10891	upregulated	Pyridoxine results in increased expression of PPARGC1A mRNA	4p15.2	A20470
Pyrimethamine	Approved Investigational Vet Approved	FOS	2353	upregulated	Pyrimethamine results in increased expression of FOS mRNA	14q24.3	A20417
Zebularine	Experimental	ANKRD6	22881	downregulated	pyrimidin-2-one beta-ribofuranoside results in decreased expression of ANKRD6 mRNA	6q15	A20985
Zebularine	Experimental	CSGALNACT2	55454	upregulated	pyrimidin-2-one beta-ribofuranoside results in increased expression of CSGALNACT2 mRNA	10q11.21	A20985
Zebularine	Experimental	CUX1	1523	downregulated	pyrimidin-2-one beta-ribofuranoside results in decreased expression of CUX1 mRNA	7q22.1	A20985

Displaying entries 61101 - 61125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability